Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Phase II Study of PX-12 in Patients With Advanced Pancreatic Cancer

This study has been terminated.
(Investigator decision)
National Cancer Institute (NCI)
Translational Genomics Research Institute
Information provided by (Responsible Party):
Cascadian Therapeutics Inc. Identifier:
First received: December 29, 2006
Last updated: April 30, 2015
Last verified: April 2015
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: April 2009
  Primary Completion Date: April 2009 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: April 30, 2015